From: Identifying overlapping mutated driver pathways by constructing gene networks in cancer
Optimal gene sets | Gene number | Exclusivity | Coverage | P-value |
---|---|---|---|---|
TP53, ATM | 2 | 98.7% | 46.6% | 1.74e-03 |
TP53, ATM, RB1 | 3 | 95.7% | 48.6% | 1.75e-04 |
APC, CDKN2A, EGFR, NF1 | 4 | 90.5% | 35.0% | 6.46e-03 |
KRAS, EGFR, NF1 | 3 | 95.2% | 60.1% | 2.99e-02 |